Eli Ipp, M.D.
In the past three years, Dr. Ipp has received grant/research support from Pfizer, Inc., R.W. Johnson, and Novo-Nordisk. He has served as a consultant for Novo-Nordisk, SmithKline Beecham Pharmaceutical and Hoechst Marion Roussel. Dr Ipp has also served on the Speakers' Bureau for Novo-Nordisk.
Release Date: 06/21/1999
Upon completion of this Cyberounds®, you should be able to:
Define and describe MODY diabetes
Discuss the molecular defects responsible for most cases of MODY
Delineate the natural history of two types of MODY.